We are live on ! Find out more
OLVIG

Oliver Lagore Vanvalin Investment Group Portfolio holdings

AUM $255M
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$269M
AUM Growth
+$16.4M
Cap. Flow
-$3.1M
Cap. Flow %
-1.15%
Top 10 Hldgs %
56.12%
Holding
916
New
65
Increased
146
Reduced
250
Closed
149
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JKHY icon
351
Jack Henry & Associates
JKHY
$10.8B
$15.5K 0.01%
95
AB icon
352
AllianceBernstein
AB
$3.4B
$15.5K 0.01%
500
-437
-47% -$12.9K
FNCL icon
353
Fidelity MSCI Financials Index ETF
FNCL
$2.42B
$15.5K 0.01%
289
PXD
354
DELISTED
Pioneer Natural Resource Co.
PXD
$15.3K 0.01%
68
-458
-87% -$107K
B
355
Barrick Mining
B
$67.9B
$14.9K 0.01%
823
-623
-43% -$10.2K
CHKP icon
356
Check Point Software Technologies
CHKP
$13.2B
$14.5K 0.01%
95
+3
+3% +$424
URNM icon
357
Sprott Uranium Miners ETF
URNM
$2.03B
$14.5K 0.01%
300
+159
+113% +$7.42K
HSCS icon
358
Heart Test Laboratories
HSCS
$7.8M
$14.5K 0.01%
846
+150
+22% +$3.69K
IAUM icon
359
iShares Gold Trust Micro
IAUM
$6.99B
$14.3K 0.01%
695
-1,264
-65% -$24.9K
ILMN icon
360
Illumina
ILMN
$29.1B
$13.9K 0.01%
+103
New +$11.9K
EL icon
361
Estee Lauder
EL
$31.7B
$13.9K 0.01%
95
-4,197
-98% -$557K
VPU
362
Vanguard Utilities ETF
VPU
$8.48B
$13.8K 0.01%
101
DIHP icon
363
Dimensional International High Profitability ETF
DIHP
$6.59B
$13.7K 0.01%
533
+154
+41% +$3.68K
DKNG icon
364
DraftKings
DKNG
$12.7B
$13.5K 0.01%
383
-149
-28% -$4.99K
HR icon
365
Healthcare Realty
HR
$6.58B
$13.5K 0.01%
783
ACHC icon
366
Acadia Healthcare
ACHC
$2.95B
$13.4K 0.01%
172
+77
+81% +$5.7K
SHY icon
367
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$13.4K 0.01%
163
-355
-69% -$28.9K
DFIV icon
368
Dimensional International Value ETF
DFIV
$21.7B
$13.4K 0.01%
389
+109
+39% +$3.56K
JPC icon
369
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$13.4K 0.01%
+1,977
New +$12.6K
DFEV icon
370
Dimensional Emerging Markets Value ETF
DFEV
$2.1B
$13.1K ﹤0.01%
520
+146
+39% +$3.48K
TMDX icon
371
Transmedics
TMDX
$3.02B
$12.9K ﹤0.01%
164
-79
-33% -$4.77K
SCHZ icon
372
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$12.9K ﹤0.01%
554
-3,036
-85% -$67.9K
GUNR icon
373
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.09B
$12.8K ﹤0.01%
313
-29,265
-99% -$1.16M
FCNCA icon
374
First Citizens BancShares
FCNCA
$25.7B
$12.8K ﹤0.01%
9
TJX icon
375
TJX Companies
TJX
$169B
$12.7K ﹤0.01%
135
-192
-59% -$17.2K

Similar funds

Oliver Lagore Vanvalin Investment Group's Q4 2023 Portfolio in Review

As of Q4 2023, Oliver Lagore Vanvalin Investment Group held 916 positions worth $269M, up 6.5% from $253M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Oliver Lagore Vanvalin Investment Group's Q4 2023 filing shows 65 new, 146 increased, 250 reduced and 149 closed positions. Its largest new stake was Direxion Auspice Broad Commodity Strategy ETF: 50,857 shares worth $1.41M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $38.2M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 5.2% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Oliver Lagore Vanvalin Investment Group's largest Q4 2023 buy was Direxion Auspice Broad Commodity Strategy ETF: 50,857 shares worth $1.41M.
  • Oliver Lagore Vanvalin Investment Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $67.1M increase.
  • Oliver Lagore Vanvalin Investment Group's biggest Q4 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $38.2M.
  • Oliver Lagore Vanvalin Investment Group fully exited State Street SPDR S&P Biotech ETF in Q4 2023, selling an estimated $266K.
  • Oliver Lagore Vanvalin Investment Group's ten largest holdings make up 56% of its $269M portfolio in Q4 2023.
  • Oliver Lagore Vanvalin Investment Group opened 65 new positions and closed 149 in Q4 2023.
  • Oliver Lagore Vanvalin Investment Group's portfolio value rose 6.5% quarter-over-quarter to $269M.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2023, filed 31 Jan 2024.